US Stock MarketDetailed Quotes

ATXS Astria Therapeutics Inc

Watchlist
  • 7.060
  • +0.040+0.57%
Close Feb 14 16:00 ET
  • 7.060
  • 0.0000.00%
Post 20:01 ET
398.43MMarket Cap-3.24P/E (TTM)

Astria Therapeutics Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Astria Therapeutics Inc Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Astria Therapeutics Inc Earnings Reports

  • Astria Therapeutics Inc | 10-Q: Q3 2024 Earnings Report

    Nov 13, 2024 16:08 ET

  • Astria Therapeutics Inc | 10-Q: Q2 2024 Earnings Report

    Aug 12, 2024 16:07 ET

  • Astria Therapeutics Inc | 10-Q: Q1 2024 Earnings Report

    May 9, 2024 16:04 ET

  • Astria Therapeutics Inc | 10-K: FY2023 Annual Report

    Mar 4, 2024 16:06 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +17.56%
    DexCom
    DXCM
    +5.92%
    Hutchmed (China)
    HCM
    +4.39%
    New Fortress Energy
    NFE
    +2.70%
    Enerpac Tool
    EPAC
    +1.85%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Jan 31, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data